Vitamin D Receptor–Dependent 1α,25(OH)2 Vitamin D3–Induced Anti-Apoptotic PI3K/AKT Signaling in Osteoblasts

Oxford University Press (OUP) - Tập 23 Số 8 - Trang 1238-1248 - 2008
Xiaoyu Zhang1, Laura P. Zanello1
1Department of Biochemistry, University of California, Riverside, California, USA

Tóm tắt

Abstract Osteoblast apoptosis plays a crucial role in bone remodeling. Physiological doses of 1α,25(OH)2-vitamin D3 (1,25D) protect osteoblasts against apoptosis by means of mechanisms only partially understood. We studied activation of an Akt survival cascade downstream of 1,25D nongenomic stimulation of phosphatidylinositide-3′-kinase (PI3K) in osteoblastic cells. We measured a dose- and time-dependent 1,25D induction of Akt phosphorylation (p-Akt) in cultured osteoblastic cells. Maximal response was achieved with 10 nM 1,25D after 5 min. We found that staurosporine (STSP)-induced apoptosis was significantly reduced in 1,25D-pretreated osteoblasts. 1,25D prosurvival effects were abolished when cells were preincubated with inhibitors of PI3K activation. By means of siRNA silencing, we proved that 1,25D induction of p-Akt requires a classic vitamin D receptor (VDR) in osteoblasts. Furthermore, non-osteoblastic CV-1 cells transfected with an enhanced green fluorescent protein (EGFP)-VDR construct responded to 1,25D treatment with a rapid p-Akt response associated with increased cell survival not detected in native, nontransfected cells. We measured increased levels of p-Akt substrates p-Bad and p-FKHR and significantly reduced activity of caspases 8 and 3/7 after 1,25D treatment. In addition, 1,25D-induced protection against apoptosis was abolished when osteoblasts were preincubated with pertussis toxin. We conclude that anti-apoptotic effects of 1,25D in osteoblasts occur through nongenomic activation of a VDR/PI3K/Akt survival pathway that includes phosphorylation of multiple p-Akt substrates and reduction of caspase activities.

Từ khóa


Tài liệu tham khảo

Aubin, 1997, Vitamin D, 313

Sambrook, 2000, Osteoporosis prevention and treatment, Med J Aust, 172, 226, 10.5694/j.1326-5377.2000.tb123917.x

Li, 1998, Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice, Endocrinology, 139, 4391, 10.1210/endo.139.10.6262

Boivin, 1987, Ultrastructural immunocytochemical localization of endogenous 1α,25-dihydroxyvitamin D3 and its receptors in osteoblasts and osteocytes from neonatal mouse and rat calvaria, J Bone Miner Res, 3, 125

Kraichely, 1998, Transcriptional activation through the vitamin D receptor in osteoblasts, Front Biosci, 3, D821, 10.2741/A325

Bellows, 1999, Expression of mRNAs for type-I collagen, bone sialoprotein, osteocalcin, and osteopontin at different stages of osteoblastic differentiation and their regulation by 1α,25 dihydroxyvitamin D3, Cell Tissue Res, 297, 249, 10.1007/s004410051353

Meszaros, 1996, Voltage-sensitive calcium channels in osteoblasts: Mediators of plasma membrane signalling events, Connect Tissue Res, 34–5, 161

Zanello, 2004, Rapid modulation of osteoblast ion channel responses by 1α,25-dihydroxyvitamin D3 requires the presence of a functional vitamin D nuclear receptor, Proc Natl Acad Sci USA, 101, 1589, 10.1073/pnas.0305802101

Zanello, 2004, Electrical responses to 1α,25-dihydroxyvitamin D3 and their physiological significance in osteoblasts, Steroids, 69, 561, 10.1016/j.steroids.2004.05.003

Zhang, 2007, 1α,25-dihydroxyvitamin D3 membrane-initiated calcium signaling modulates exocytosis and cell survival, J Steroid Biochem Mol Biol, 103, 457, 10.1016/j.jsbmb.2006.11.002

Wu, 2007, 1α,25-dihydroxyvitamin D3 antiproliferative actions involve vitamin D receptor-mediated activation of MAPK pathways and AP-1/p21waf1 upregulation in human osteosarcoma, Cancer Lett, 254, 75, 10.1016/j.canlet.2007.02.013

Le Mellay, 1999, Gαq/11 and Gγ proteins and membrane signaling of calcitriol and estradiol, J Cell Biochem, 75, 138, 10.1002/(SICI)1097-4644(19991001)75:1<138::AID-JCB14>3.0.CO;2-I

Vertino, 2005, Nongenotropic, anti-apoptotic signaling of 1α,25-dihydroxyvitamin D3 and analogs through the ligand binding domain of the vitamin D receptor in osteoblasts and osteocytes. Mediation by Src, phosphatidylinositol 3-, and JNK kinases, J Biol Chem, 280, 14130, 10.1074/jbc.M410720200

Duque, 2004, Vitamin D inhibits Fas ligand-induced apoptosis in human osteoblasts by regulating components of both the mitochondrial and Fas-related pathways, Bone, 35, 57, 10.1016/j.bone.2004.03.005

Morales, 2004, Effects of 1α,25-dihydroxyvitamin D3 and growth hormone on apoptosis and proliferation in UMR 106 osteoblast-like cells, Endocrinology, 145, 87, 10.1210/en.2003-0718

Prince, 2007, Calcium and vitamin D: For whom and when, Menopause Int, 13, 35, 10.1258/175404507780456755

Kaye, 2007, Bone health and oral health, J Am Dent Assoc, 138, 616, 10.14219/jada.archive.2007.0232

Boonen, 2004, The need for clinical guidance in the use of calcium and vitamin D in the management of osteoporosis: A consensus report, Osteoporos Int, 15, 511, 10.1007/s00198-004-1621-6

Vanhaesebroeck, 2000, The PI3K-PDK1 connection: More than just a road to PKB, Biochem J, 346, 561, 10.1042/bj3460561

Song, 2005, The activation of Akt/PKB signaling pathway and cell survival, J Cell Mol Med, 9, 59, 10.1111/j.1582-4934.2005.tb00337.x

Datta, 1999, Cellular survival: A play in three Akts, Genes Dev, 13, 2905, 10.1101/gad.13.22.2905

Datta, 1997, Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery, Cell, 91, 231, 10.1016/S0092-8674(00)80405-5

Lamkanfi, 2003, Caspases: Their Role in Cell Death and Survival, 1

Tafani, 2001, Induction of the mitochondrial permeability transition mediates the killing of HeLa cells by staurosporine, Cancer Res, 61, 2459

Zhang, 2004, Staurosporine induces apoptosis of melanoma by both caspase-dependent and -independent apoptotic pathways, Molec Cancer Ther, 3, 187, 10.1158/1535-7163.187.3.2

Mizwicki, 2004, Identification of an alternative ligand-binding pocket in the nuclear vitamin D receptor and its functional importance in 1α,25(OH)2-vitamin D3 signaling, Proc Natl Acad Sci USA, 101, 12876, 10.1073/pnas.0403606101

Huhtakangas, 2004, The vitamin D receptor is present in caveolae-enriched plasma membranes and binds 1α,25-dihydroxyvitamin D3 in vivo and in vitro, Mol Endocrinol, 18, 2660, 10.1210/me.2004-0116

Gidley, 2006, Lysophosphatidic acid cooperates with 1α,25-dihydroxyvitamin D3 in stimulating human MG63 osteoblast maturation, Prostaglandins Other Lipid Mediat, 80, 46, 10.1016/j.prostaglandins.2006.04.001

Zanello, 1997, Stimulation by 1α,25-dihydroxyvitamin D3 of whole cell chloride currents in osteoblastic ROS 17/2.8 cells: A structure-function study, J Biol Chem, 272, 22617, 10.1074/jbc.272.36.22617

Perlman, 1998, Bax-mediated cell death by the Gax homeoprotein requires mitogen activation but is independent of cell cycle activity, EMBO J, 17, 3576, 10.1093/emboj/17.13.3576

Lamkanfi, 2007, Caspases in cell survival, proliferation and differentiation, Cell Death Differ, 14, 44, 10.1038/sj.cdd.4402047

Tafani, 2001, Induction of the mitochondrial permeability transition mediates the killing of HeLa cells by staurosporine, Cancer Res, 61, 2459

Cardone, 1998, Regulation of cell death protease caspase-9 by phosphorylation, Science, 282, 1318, 10.1126/science.282.5392.1318

Zhang, 2003, Staurosporine induces apoptosis of melanoma by both caspase-dependent and -independent apoptotic pathways, Mol Cancer Ther, 3, 187, 10.1158/1535-7163.187.3.2

Nemere, 2004, Ribozyme knockdown functionally links a 1α,25-dihydroxyvitamin D3 membrane binding protein (1,25D3-MARRS) and phosphate uptake in intestinal cells, Proc Natl Acad Sci USA, 101, 7392, 10.1073/pnas.0402207101

Boyan, 2002, Evidence for distinct membrane receptors for 1α,25-dihydroxyvitamin D3 and 24R,25-(OH)2 vitamin D3 in osteoblasts, Steroids, 67, 235, 10.1016/S0039-128X(01)00160-X

Capiati, 2002, 1α,25(OH)2-vitamin D3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells, J Cell Biochem, 86, 128, 10.1002/jcb.10191

Erben, 2002, Deletion of deoxyribonucleic acid binding domain of the vitamin D receptor abrogates genomic and nongenomic functions of vitamin D, Mol Endocrinol, 16, 1524, 10.1210/mend.16.7.0866

Wyckoff, 2001, Plasma membrane estrogen receptors are coupled to endothelial nitric-oxide synthase through Gai, J Biol Chem, 276, 27071, 10.1074/jbc.M100312200

Razandi, 2003, Proximal events in signaling by plasma membrane estrogen receptors, J Biol Chem, 278, 2701, 10.1074/jbc.M205692200

Vanhaesebroeck, 2000, The PI3K-PDK1 connection: More than just a road to PKB, Exp Cell Res, 346, 561

Chen, 2003, Pertussis toxin-sensitive Gαi protein and ERK-dependent pathways mediate ultrasound promotion of osteogenic transcription in human osteoblasts, FEBS Lett, 554, 154, 10.1016/S0014-5793(03)01157-8

De Haes, 2004, Molecular pathways involved in the anti-apoptotic effect of 1α,25-dihydroxyvitamin D3 in primary human keratinocytes, J Cell Biochem, 93, 951, 10.1002/jcb.20227

Ma, 2006, Role of nongenomic activation of phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase 1/2 pathways in 1,25D3-mediated apoptosis in squamous cell carcinoma cells, Cancer Res, 66, 8131, 10.1158/0008-5472.CAN-06-1333

Diaz, 2000, Apoptosis is induced by the active metabolite of vitamin D3 and its analogue EB1089 in colorectal adenoma and carcinoma cells: Possible implications for prevention and therapy, Cancer Res, 60, 2304

Manggau, 2001, 1α,25-dihydroxyvitamin D3 protects human keratinocytes from apoptosis by the formation of sphingosine-1-phosphate, J Invest Dermatol, 117, 1241, 10.1046/j.0022-202x.2001.01496.x

Thomas, 2005, Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells, Endocrinology, 146, 624, 10.1210/en.2004-1064

Srivastava, 2005, Rapid, nongenomic responses to ecdysteroids and catecholamines mediated by a novel Drosophila G-protein-coupled receptor, J Neurosci, 25, 6145, 10.1523/JNEUROSCI.1005-05.2005